CO5690543A2 - Derivados de arilcicloalquilo con cadenas laterales ramificadas en calidad de moduladores de receptores ppar, metodo para su produccion y sus uso como medicamentos - Google Patents
Derivados de arilcicloalquilo con cadenas laterales ramificadas en calidad de moduladores de receptores ppar, metodo para su produccion y sus uso como medicamentosInfo
- Publication number
- CO5690543A2 CO5690543A2 CO05085501A CO05085501A CO5690543A2 CO 5690543 A2 CO5690543 A2 CO 5690543A2 CO 05085501 A CO05085501 A CO 05085501A CO 05085501 A CO05085501 A CO 05085501A CO 5690543 A2 CO5690543 A2 CO 5690543A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- arilcicloalquilo
- ramified
- medications
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1.- Un compuesto de la fórmula Ien la que el anillo A es cicloalcanodiilo (C3-C8) o cicloalquenodiilo (C3-C8), donde en los anillos cicloalcanodiilo o cicloalquenodiilo uno o más átomos de carbono pueden reemplazarse por átomos de oxígeno;R es NR1R2 u OR1, arilo (C6-C10) o heteroarilo (C5-C12), donde el heteroarilo puede contener de uno a tres heteroátomos idénticos o diferentes seleccionados entre el grupo compuesto por N, O y S;R1 y R2, independientemente entre sí, son H, alquilo (C1-C6), cicloalquilo (C3-C8) o arilo (C6-C10), donde arilo puede estar sin sustituir o sustituido con F, CI o alquilo (C1-C4);R3 es cicloalquilo (C3-C6) o alquilo (C1-C10), que están sin sustituir o sustituidos con fenilo, piridilo, morfolinilo, cicloalquilo (C3-C6), donde fenilo, por su parte, puede estar sustituido con cloro o alquilo (C1-C4);X es alcanodiilo (C1-C6), donde uno o más átomos de carbono en el grupo alcanodiilo pueden reemplazarse por átomos de oxígeno;Y es alcanodiilo (C1-C6), donde uno o más átomos de carbono en el grupo alcanodiilo pueden reemplazarse por átomos de oxígeno;R4 es H, alquilo (C1-C4);R5 es alquilo (C1-C4);y sus sales fisiológicamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10308352A DE10308352A1 (de) | 2003-02-27 | 2003-02-27 | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5690543A2 true CO5690543A2 (es) | 2006-10-31 |
Family
ID=32841932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO05085501A CO5690543A2 (es) | 2003-02-27 | 2005-08-26 | Derivados de arilcicloalquilo con cadenas laterales ramificadas en calidad de moduladores de receptores ppar, metodo para su produccion y sus uso como medicamentos |
Country Status (22)
Country | Link |
---|---|
US (1) | US7220876B2 (es) |
EP (1) | EP1601643B1 (es) |
JP (1) | JP2006519196A (es) |
KR (1) | KR20050113195A (es) |
CN (1) | CN100417641C (es) |
AR (1) | AR043429A1 (es) |
AT (1) | ATE503740T1 (es) |
AU (1) | AU2004215675B2 (es) |
BR (1) | BRPI0407858A (es) |
CA (1) | CA2516626A1 (es) |
CO (1) | CO5690543A2 (es) |
DE (2) | DE10308352A1 (es) |
HR (1) | HRP20050737A2 (es) |
MA (1) | MA27740A1 (es) |
MX (1) | MXPA05009054A (es) |
NO (1) | NO20054380L (es) |
PE (1) | PE20040957A1 (es) |
PL (1) | PL377736A1 (es) |
RU (1) | RU2005130004A (es) |
TW (1) | TW200505831A (es) |
WO (1) | WO2004076402A1 (es) |
ZA (1) | ZA200505762B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399777B2 (en) * | 2001-08-31 | 2008-07-15 | Sanofi-Aventis Deutschland Gmbh | Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals |
BRPI0515015A (pt) | 2004-08-11 | 2008-07-01 | Kyorin Seiyaku Kk | derivado cìclico de ácido aminobenzóico; medicamento; agonista ppar(alpha); agonista duplo ppar(alpha), y; agonista duplo ppar(alpha), (delta); modulador ppar; agente lipìdeo; agente profilático ou terapêutico compreendendo pelo menos um dos derivados cìclicos de ácido aminobenzóico ou sal do mesmo farmacêuticamente aceitável |
KR20070116644A (ko) * | 2005-03-23 | 2007-12-10 | 교린 세이야꾸 가부시키 가이샤 | 신규 환상 아미노페닐알칸산 유도체 |
RU2008112198A (ru) | 2005-09-29 | 2009-10-10 | Санофи-Авентис (Fr) | Производные фенил-1,2,4-оксадиазолона, способы их получения и их применение в качестве фармацевтических средств |
US20140024790A1 (en) | 2011-02-18 | 2014-01-23 | Haif Al-Shammari | Multinuclear metallocene catalyst complexes for olefin polymerisation and copolymerisation and method of preparing thereof |
SG11201707219VA (en) * | 2015-03-09 | 2017-10-30 | Lubrizol Corp | Method of lubricating an internal combustion engine |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61716B1 (en) * | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
FR2663336B1 (fr) | 1990-06-18 | 1992-09-04 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
IL108633A (en) | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
JP3144624B2 (ja) | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
IL125071A0 (en) | 1996-01-17 | 1999-01-26 | Novo Nordisk As | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives their preparation and use |
CN1271086C (zh) | 1996-08-30 | 2006-08-23 | 诺沃挪第克公司 | Glp-1衍生物 |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
IL127296A (en) | 1996-12-31 | 2003-01-12 | Reddy Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
GB9703492D0 (en) * | 1997-02-20 | 1997-04-09 | Smithkline Beecham Plc | Novel compounds |
US6057338A (en) * | 1997-04-04 | 2000-05-02 | Merck & Co., Inc. | Somatostatin agonists |
DE19726167B4 (de) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung |
KR20010021936A (ko) | 1997-07-16 | 2001-03-15 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용 |
CO4970713A1 (es) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
US6221897B1 (en) | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
US6525069B1 (en) * | 1998-12-18 | 2003-02-25 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
AU3956900A (en) | 1999-04-16 | 2000-11-02 | Boehringer Ingelheim International Gmbh | Substituted imidazoles, their preparation and use |
AU782404B2 (en) | 1999-04-28 | 2005-07-28 | Sanofi-Aventis Deutschland Gmbh | Tri-aryl acid derivatives as PPAR receptor ligands |
YU72201A (sh) | 1999-04-28 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | Derivati di-aril kiseline kao ppar receptorski ligandi |
EP1175421A1 (en) | 1999-04-30 | 2002-01-30 | Neurogen Corporation | 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
CA2376919C (en) | 1999-06-18 | 2008-11-04 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
EP1196610A2 (en) | 1999-07-09 | 2002-04-17 | Cohesion Technologies, Inc. | Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
EP1204654B1 (en) | 1999-07-29 | 2003-07-23 | Eli Lilly And Company | Benzofurylpiperazines: 5-ht2c serotonin receptor agonists |
GB9919411D0 (en) * | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
DE50011035D1 (de) | 1999-09-01 | 2005-09-29 | Aventis Pharma Gmbh | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
TWI260321B (en) | 1999-09-22 | 2006-08-21 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
NZ518925A (en) | 1999-12-03 | 2004-06-25 | Astrazeneca Ab | Crystalline form of (S)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
SE9904413D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
PT1283735E (pt) | 2000-03-31 | 2009-03-19 | Prosidion Ltd | Processo para melhoramento da sinalização de ilhéus na diabetes mellitus e para a sua prevenção |
US6770133B2 (en) | 2000-04-25 | 2004-08-03 | Kyorin Pharmaceutical Co., Ltd. | Stable crystal of thiazolidinedione derivative and process for producing the same |
ES2287120T3 (es) | 2000-04-28 | 2007-12-16 | Asahi Kasei Pharma Corporation | Nuevos compuestos biciclicos. |
AU5959201A (en) | 2000-05-11 | 2001-11-20 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
WO2001091752A1 (en) | 2000-05-30 | 2001-12-06 | Merck & Co., Inc. | Melanocortin receptor agonists |
PT1294682E (pt) | 2000-06-09 | 2004-09-30 | Aventis Pharma Gmbh | Derivados de acilfenilureia processo para a sua preparacao e sua aplicacao como medicamentos |
JP2002201171A (ja) * | 2000-10-27 | 2002-07-16 | Toa Eiyo Ltd | ウレアカルボン酸誘導体 |
TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
WO2002046146A1 (fr) * | 2000-12-05 | 2002-06-13 | Kyorin Pharmaceutical Co., Ltd. | Derives d'acide carboxylique substitues |
NZ526593A (en) | 2000-12-21 | 2005-02-25 | Aventis Pharma Gmbh | Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
JP2002201127A (ja) * | 2000-12-28 | 2002-07-16 | Pola Chem Ind Inc | ウレア誘導体 |
CA2438551A1 (en) * | 2001-02-15 | 2002-08-22 | Pfizer Products Inc. | Ppar agonists |
PE20021091A1 (es) | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
DE10154689A1 (de) | 2001-11-09 | 2003-05-22 | Probiodrug Ag | Substituierte Aminoketonverbindungen |
WO2003005025A1 (en) * | 2001-07-03 | 2003-01-16 | Biovitrum Ab | Methods for identifying compounds modulating the activity of ppar-gamma |
IL160556A0 (en) | 2001-08-31 | 2004-07-25 | Aventis Pharma Gmbh | Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
AU2003207432A1 (en) * | 2002-02-05 | 2003-09-02 | Eli Lilly And Company | Urea linker derivatives for use as ppar modulators |
DE10215908B4 (de) | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
DE10215907A1 (de) | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
DE10225635C1 (de) | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
US7820682B2 (en) * | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
-
2003
- 2003-02-27 DE DE10308352A patent/DE10308352A1/de not_active Withdrawn
-
2004
- 2004-02-19 JP JP2006501889A patent/JP2006519196A/ja active Pending
- 2004-02-19 WO PCT/EP2004/001583 patent/WO2004076402A1/de active Application Filing
- 2004-02-19 AT AT04712515T patent/ATE503740T1/de active
- 2004-02-19 MX MXPA05009054A patent/MXPA05009054A/es active IP Right Grant
- 2004-02-19 DE DE502004012351T patent/DE502004012351D1/de not_active Expired - Lifetime
- 2004-02-19 EP EP04712515A patent/EP1601643B1/de not_active Expired - Lifetime
- 2004-02-19 AU AU2004215675A patent/AU2004215675B2/en not_active Ceased
- 2004-02-19 KR KR1020057015772A patent/KR20050113195A/ko not_active Application Discontinuation
- 2004-02-19 CA CA002516626A patent/CA2516626A1/en not_active Abandoned
- 2004-02-19 PL PL377736A patent/PL377736A1/pl not_active Application Discontinuation
- 2004-02-19 RU RU2005130004/04A patent/RU2005130004A/ru not_active Application Discontinuation
- 2004-02-19 BR BRPI0407858-6A patent/BRPI0407858A/pt not_active IP Right Cessation
- 2004-02-19 CN CNB2004800054773A patent/CN100417641C/zh not_active Expired - Fee Related
- 2004-02-25 TW TW093104701A patent/TW200505831A/zh unknown
- 2004-02-27 AR ARP040100632A patent/AR043429A1/es not_active Application Discontinuation
- 2004-02-27 PE PE2004000202A patent/PE20040957A1/es not_active Application Discontinuation
- 2004-02-27 US US10/789,323 patent/US7220876B2/en active Active
-
2005
- 2005-07-19 ZA ZA200505762A patent/ZA200505762B/en unknown
- 2005-08-26 CO CO05085501A patent/CO5690543A2/es not_active Application Discontinuation
- 2005-08-26 MA MA28463A patent/MA27740A1/fr unknown
- 2005-08-26 HR HR20050737A patent/HRP20050737A2/xx not_active Application Discontinuation
- 2005-09-21 NO NO20054380A patent/NO20054380L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US7220876B2 (en) | 2007-05-22 |
TW200505831A (en) | 2005-02-16 |
AU2004215675B2 (en) | 2010-01-21 |
JP2006519196A (ja) | 2006-08-24 |
WO2004076402A1 (de) | 2004-09-10 |
CN100417641C (zh) | 2008-09-10 |
US20040209873A1 (en) | 2004-10-21 |
PE20040957A1 (es) | 2005-01-31 |
DE502004012351D1 (de) | 2011-05-12 |
RU2005130004A (ru) | 2006-01-27 |
MXPA05009054A (es) | 2005-10-19 |
EP1601643A1 (de) | 2005-12-07 |
KR20050113195A (ko) | 2005-12-01 |
BRPI0407858A (pt) | 2006-03-01 |
CA2516626A1 (en) | 2004-09-10 |
EP1601643B1 (de) | 2011-03-30 |
DE10308352A1 (de) | 2004-09-09 |
ATE503740T1 (de) | 2011-04-15 |
ZA200505762B (en) | 2006-05-31 |
HRP20050737A2 (en) | 2006-07-31 |
AR043429A1 (es) | 2005-07-27 |
AU2004215675A1 (en) | 2004-09-10 |
MA27740A1 (fr) | 2006-02-01 |
PL377736A1 (pl) | 2006-02-20 |
CN1753866A (zh) | 2006-03-29 |
NO20054380L (no) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5690543A2 (es) | Derivados de arilcicloalquilo con cadenas laterales ramificadas en calidad de moduladores de receptores ppar, metodo para su produccion y sus uso como medicamentos | |
AR113748A1 (es) | Proceso estereoselectivo para preparar derivados de piridona policíclicos sustituidos | |
CO5690579A2 (es) | Derivados de diarilcicloalquilo, metodo para su produccion y su uso como medicamentos | |
AR055959A1 (es) | Derivados espiro para la modulacion de actividad de crth2 | |
CO5690548A2 (es) | N-arilheterociclos sustituidos, procedimientos para su preparacion y su empleo como medicamentos | |
AR057088A1 (es) | Compuestos quimicos | |
TW200510781A (en) | Composition for optical film, and optical film | |
CO5700817A2 (es) | Compuesto pentaciclico heteroaromatico y uso medicinal del mismo | |
AR058562A1 (es) | Derivados de pirimido [4,5 b] (1,4) oxazinas , procedimientos de obtencion y su uso como inhibidores de acetil coa y dgat 1 | |
CO5690643A2 (es) | Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos | |
PE20060626A1 (es) | Aminas policiclicas sustituidas con arilo como antagonistas de mch1r | |
AR064459A1 (es) | Derivados de sulfonamida | |
ES2167959T3 (es) | Nafto(2,1-b)piranos fotocromicos fusionados con indeno. | |
PE20020195A1 (es) | AGONISTAS ß3 ADRENERGICOS | |
AR052903A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno. | |
CO6220952A2 (es) | Nuevos derivados de 3-([1,2,4]triazolo[4,3-a]piridin-7-il)benzamida | |
CO5640117A2 (es) | Derivados de 2,4-diamonopirimidina | |
AR055144A1 (es) | Inhibidor de secrecion acida | |
AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
AR065863A1 (es) | Derivados de imidazolidinona | |
CY1116391T1 (el) | Αιθινυλο παραγωγα ως θετικοι αλλοστερικοι ρυθμιστες του mglur5 | |
CY1116388T1 (el) | 5-(φαινυλο/πυριδινυλο-αιθινυλο)-2-πυριδινο/2-πυριμιδινο-καρβοξαμιδια ως mglur5 ρυθμιστες | |
AR050283A1 (es) | Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparacion y su aplicacion en terapeuticas. | |
UY31604A1 (es) | Compuestos tricíclicos y uso de los mismos | |
AR050153A1 (es) | Beta-agonistas, procedimiento para su preparacion y su uso como medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |